Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on June 23, 2026. The filing reports final voting tallies for two proposals: election of two Class III directors (Jae Chang and David H. Park) and ratification of CBIZ CPAs P.C. as independent auditor. Both proposals passed with overwhelming support, and the disclosure includes detailed vote counts and quorum information, which is the standard content for Item 5.07 shareholder vote results.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-26
Item 1.01
The filing discloses Amendment No. 1 to the Senior Credit Facilities, which refinanced $600 million in term loans at reduced interest rate margins and repriced the revolving credit commitments. While technically an amendment to an existing credit agreement rather than a new debt issuance, the refinancing of $600 million in principal with new terms and the participation of new lenders constitutes a material modification of the registrant's direct financial obligations. This is material to investors as it affects the company's debt structure, interest expense, and financial flexibility.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-06-26
SK Telecom's board approved a capital contribution commitment to acquire 1,198 newly issued shares of SK hynix NAND Product Solutions Corp. for 738.384 billion Won (approximately 5.70% of SK Telecom's total shareholders' equity), representing a material equity investment in an affiliated company. The transaction is structured as a commitment agreement with a scheduled completion date of June 25, 2030, and is explicitly undertaken to facilitate synergies with the Company's AI business, meeting the definition of material acquisition activity under Item 1.01.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-26
The filing announces multiple executive leadership appointments effective 1 July and 1 September 2026, including Jessica Farrell as President North America, Edgar Basto transitioning to Chief Enterprise Performance Officer, and Geraldine Slattery assuming expanded responsibilities as President Australia. While Brandon Craig's CEO appointment was previously announced on 18 March 2026, this disclosure announces the broader executive team restructuring and new appointments that would materially affect investor assessment of leadership capacity and organizational structure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-26
This 6-K furnishes the notice of resolutions from the 24th Ordinary General Meeting of Shareholders held on June 26, 2026. It discloses the results of shareholder votes on four proposals: approval of dividend appropriation (¥79 per share), approval of articles amendments including a 2-for-1 stock split effective October 1, 2026, election of thirteen directors (including one new director, Takeshi Mikami), and disapproval of a shareholder proposal on share repurchase authority. These are material shareholder vote results under Item 5.07 equivalent, affecting capital structure, governance, and dividend policy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
Item 5.02
The Board unanimously elected Anne DelSanto as an independent director effective July 1, 2026, increasing the Board size from six to seven members. Ms. DelSanto, with 30+ years of technology industry experience in cloud computing, SaaS, and AI, was also appointed to the Compensation Committee, strengthening the Board's expertise in areas aligned with the Company's strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
Item 5.02
Jade Biosciences appointed Mark Eisner, M.D., M.P.H., to its Board of Directors as a Class I director and member of the Nominating and Corporate Governance Committee, effective June 25, 2026. Dr. Eisner brings 25+ years of clinical development and immunology leadership, including prior roles as Chief Medical Officer at Vir Biotechnology and FibroGen, and 11 years at Genentech/Roche, directly supporting the company's pipeline advancement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-26
Item 2.02
Cineverse issued a press release on June 26, 2026 announcing financial results for the three and twelve months ended March 31, 2026 (Q4 FY 2026 and full-year FY 2026). The disclosure includes quarterly and annual revenue ($26.0M and $65.7M respectively), net income, Adjusted EBITDA, and forward guidance for fiscal 2027 ($115–$120M revenue, $10–$20M Adjusted EBITDA). This is a standard earnings release attached as Exhibit 99.1 and disclosed under Item 2.02, which is material to investors assessing the company's financial performance and growth trajectory.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-26
Item 8.01
The Company has agreed to issue 3,453,237 common shares valued at $4,800,000 to settle and terminate an offtake agreement with Vox Royalty entities. This is a material issuance of equity securities as consideration for a contract termination, which will be registered on Form S-3. The substantial share count and dollar value represent a dilutive capital event that would materially affect investor assessment of ownership and capitalization.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-26
Item 5.07
This Item 5.07 discloses the results of a special shareholder meeting held on June 22, 2026, where shareholders voted on the Scheme of Arrangement to approve Wave Life Sciences' redomiciliation from Singapore to another jurisdiction. The filing reports final voting results (155,190,836 shares voted in favor, 78,429 against, with 87 shareholders voting in favor and 0 against), which is the core disclosure required under Item 5.07. The redomiciliation is a material corporate restructuring requiring court and shareholder approval.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-26
Item 5.02
Donald S. Poulton's retirement effective June 30, 2026, from his position as Chief Executive Officer of Medallion Bank is the principal disclosed action. While the section also addresses compensatory arrangements (accelerated vesting of 92,978 restricted shares and discretionary bonus eligibility), the core event is the departure of the CEO. The compensation details are ancillary consequences of the retirement rather than the primary focus of the disclosure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-26
Item 3.03
Quince Therapeutics effectuated a 1-for-20 reverse stock split on June 26, 2026, pursuant to stockholder approval obtained on June 11, 2026, via a Certificate of Amendment filed with Delaware. The reverse split modifies the capital structure and trading characteristics of the company's common stock by combining shares, though it does not alter ownership percentages or the fundamental rights and preferences of the securities.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-26
The 6-K discloses the results of Pharvaris N.V.'s Annual General Meeting of Shareholders held on June 26, 2026, including shareholder votes on adoption of annual accounts, appointment of external auditor (PricewaterhouseCoopers Accountants N.V.), director discharge, share acquisition authorization extension, and re-appointment of Dr. Margareta Elisabeth Björk as non-executive director. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the outcomes (particularly auditor appointment and director re-appointment) are material to investors' assessment of governance and financial oversight.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-06-26
Item 8.01
Mills Music Trust issued a Quarterly Distribution Report disclosing a distribution of $93,323 ($0.3360 per Trust Unit) to Unit Holders from Q1 2026 royalty payments received from Sony Music Publishing. This is a routine but material distribution of cash to security holders from trust income, consistent with the trust's ordinary business of collecting and distributing royalty payments on its copyright catalogue.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-26
EX-99.1
This exhibit is an official announcement of poll results from XPeng Inc.'s Annual General Meeting held on June 26, 2026. It discloses the voting outcomes on ten resolutions, including adoption of audited financial statements, re-election of independent non-executive directors (Donghao Yang, HongJiang Zhang, Yudong Chen), authorization of director remuneration, re-appointment of auditors (PricewaterhouseCoopers), and approval of general mandates for share issuance, repurchase, and amendments to the memorandum and articles of association. All resolutions passed with disclosed vote counts and percentages, meeting the definition of shareholder_vote_results under Item 5.07 equivalent disclosure.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-26
The 6-K furnishes a Pricing Agreement dated June 18, 2026 for three series of Fixed-to-Floating Rate Senior Callable Notes (due 2030, 2032, and 2037) with coupon rates of 4.911%, 5.102%, and 5.586% respectively, along with supplemental indentures and global security forms. This constitutes creation of new direct financial obligations through debt issuance, a material capital event for a large financial institution.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-26
Item 2.02
Fidelity Private Credit Fund disclosed its financial results and performance as of May 31, 2026, including monthly and period-to-date net returns across share classes, NAV per share of $24.88, distribution rate of 9.21%, total assets of $2.6 billion, and portfolio metrics.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
Item 3.02
Silver Point Private Credit Fund issued and sold 745,920 unregistered common shares for approximately $20 million pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-26
Item 8.01
The Board of Trustees declared a regular monthly dividend of $0.1575 per share payable to common shareholders as of June 30, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-26
Item 2.02
Worthington Enterprises disclosed unaudited financial results for the fourth quarter and full fiscal year 2026 ended May 31, 2026, via conference call transcript, reporting net sales of $1.4 billion (20% growth), adjusted EBITDA of $296 million (12% growth), and earnings per share of $3.14 GAAP and $3.37 adjusted, with segment performance and management commentary on business operations and outlook.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-26
Item 5.02
The Compensation Committee approved on June 22, 2026, a special leadership retention performance share award of 25,000 Performance Shares each for four named executives (Colin J. Souza, Patrick J. Kennedy, Steven M. Caravati, and James R. Bowes), subject to performance-based vesting conditions tied to adjusted EBITDA and return on assets targets for fiscal 2027–2030 and a retention condition.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-26
Item 5.02
Kristen L. Soler, Executive Vice President and Chief Human Resources Officer, is departing the Company effective June 26, 2026, to pursue other opportunities. The disclosure explicitly states she will serve in an advisory capacity through July 10, 2026, and will receive severance payment under the termination without due cause provision of her employment agreement. This is a clear executive departure of a named officer.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-26
Item 5.02
Robert Lally, Senior Vice President of Finance and Operations and principal accounting officer, resigned effective July 22, 2026. The departure of a principal accounting officer is material to investors as it affects financial reporting oversight and internal controls. The filing explicitly states the resignation was not due to disagreement, but the loss of this key finance and accounting leadership role remains a material event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-26
Item 1.01
ALX Oncology entered into a loan and security agreement with HSBC Ventures USA Inc. on June 25, 2026, establishing a secured multi-tranche term loan facility of up to $50 million with $10 million borrowed at closing, maturing June 1, 2030. The company simultaneously terminated its prior loan agreement dated October 27, 2022, by using proceeds from the new facility to pay off all outstanding amounts, constituting a material debt refinancing transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
Stockholders voted at the Annual Meeting on five proposals: election of two Class III directors (Bridget Martell and Carole Nuechterlein), ratification of Ernst & Young LLP as auditor, approval of an amendment to the 2020 Employee Stock Purchase Plan (ESPP) reserving an additional 500,000 shares and eliminating the evergreen provision, advisory vote on named executive officer compensation, and advisory vote on the frequency of future compensation votes. The filing discloses the tabulated voting results for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a clear disclosure of shareholder vote results from Cambium Networks' annual general meeting held on June 25, 2026. The filing reports voting outcomes on seven proposals including director elections, auditor ratification, say-on-pay, reverse share split approval, and bylaw amendments. Item 5.07 is the designated 8-K item for shareholder vote results, and the detailed vote tallies for each proposal directly match that requirement. The reverse share split approval and related amendments are material corporate actions requiring shareholder approval.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
Item 3.02
The filing discloses an unregistered sale of 8,677,493 common shares for $250 million on June 23, 2026, pursuant to capital drawdown notices to investors. This is a classic dilutive equity issuance exempt under Section 4(a)(2) and Regulation D, representing a material capital raise that would affect investor assessment of ownership dilution and the company's capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
MYOMO held its Annual Meeting of Stockholders on June 25, 2026, with shareholders voting on seven matters including director elections, executive compensation advisory vote, auditor ratification, stock plan amendment, charter amendment, director classification proposal, and meeting adjournment authority.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-06-26
Item 5.02
Stockholders approved an amendment to the Myomo 2018 Stock Option and Incentive Plan increasing available shares by 1,833,000, expanding the pool of equity grants available to officers and directors.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-06-26
EX-99.1
This announcement discloses a grant of 1,890,627 restricted share units (RSUs) to certain employees of Bilibili Inc. pursuant to the Second Amended and Restated 2018 Share Incentive Plan on June 26, 2026. The grant represents approximately 0.45% of total shares outstanding and includes vesting schedules (June 2027–2030) and clawback provisions. This is a compensatory arrangement for employees and falls squarely within exec_compensation disclosure requirements, as it involves equity grants to incentivize and retain key personnel.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
Item 3.02
The filing discloses an unregistered sale of 1,527,300.4964 common shares for $40 million on June 24, 2026, pursuant to capital drawdown notices. This is a classic dilutive issuance under Item 3.02, exempt from registration under Section 4(a)(2) and Regulation D. The $40 million capital raise is material to a trust-based investment vehicle and would affect investor assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-06-26
The 6-K discloses court approval and shareholder approval of a statutory scheme of arrangement and redomiciliation whereby Marex Group plc (UK) will be replaced by New Marex (Bermuda) as the parent holding company, with each ordinary share cancelled and exchanged for one new ordinary share. This constitutes a material change of control and corporate restructuring. The effective date is July 1, 2026, with trading transition on Nasdaq under the same ticker symbol.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-26
Item 3.02
The filing discloses an unregistered sale of 1,146,788.9908 common shares for $30,000,000 on June 24, 2026, pursuant to capital drawdown notices under Section 4(a)(2) and Regulation D/S exemptions. This is a classic dilutive equity issuance that would materially affect investor assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 92%
filed 2026-06-26
EX-99.1
This exhibit is a post-buyback public announcement for Wipro's repurchase of 60 crore (600 million) fully paid equity shares at ₹250 per share. Share buyback programs are a form of capital return to shareholders and fall within the dividend_distribution category, which explicitly includes "share-repurchase programs." The material scale (600 million shares) and formal regulatory submission to BSE, NSE, and NYSE make this a material disclosure affecting investor assessment of capital allocation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This Item 5.07 disclosure reports the results of BCP Investment Corporation's annual meeting of stockholders held on June 25, 2026, including voting outcomes for two proposals: election of three directors (Jennifer Kwon Chou, Joseph Morea, and Robert Warshauer) and ratification of Deloitte & Touche LLP as independent auditor. The tabulated vote counts for each proposal are provided, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-26
Item 5.02
The filing discloses two executive changes: the departure of Chief Accounting Officer Yanina Grant-Huerta (effective July 17, 2026) and the appointment of Kevin G. Sarney as interim CFO and principal accounting officer (effective June 26, 2026). While both events are disclosed, the principal action centers on the appointment of Sarney to fill the critical CFO and principal accounting officer roles, making exec_appointment the most salient classification. The departure is secondary context to the appointment action.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-26
Item 5.07
This is a clear disclosure of shareholder vote results from BC Partners Lending Corporation's annual meeting held on June 25, 2026. The filing reports voting outcomes for two proposals: election of directors (Ted Goldthorpe and George Grunebaum) and ratification of Deloitte & Touche LLP as independent auditor, with complete vote tabulations. This is a mandatory Item 5.07 disclosure of annual meeting results, which is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-26
Item 8.01
National Fuel Gas Company disclosed a material acquisition of Vectren Energy Delivery of Ohio, LLC from CenterPoint Energy Resources Corp. for $2.62 billion, with PUCO regulatory approval obtained on June 24, 2026, and expected closing in Q4 2026. This is a significant M&A transaction meeting the definition of a material acquisition under Item 1.01/2.01, disclosed under Item 8.01 as an update on a previously announced transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a clear disclosure of shareholder voting results from StandardAero's 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing reports the outcomes of three proposals: election of three Class II directors (Douglas V. Brandely, Wendy M. Masiello, and Stefan Weingartner), ratification of PricewaterhouseCoopers LLP as independent auditor, and non-binding approval of executive compensation. All three proposals passed with substantial majorities. This is a routine but material governance disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-26
Item 8.01
The Company issued 4,761,905 shares of common stock to Palantir Technologies as consideration for software license fees and professional services. This is a dilutive equity issuance registered under Form S-3, representing a material capital event that would affect shareholder ownership and the total mix of information available to investors regarding the Company's capitalization and obligations to Palantir.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-26
Item 4.01
The filing discloses the dismissal of Baker Tilly US, LLP as the Company's independent registered public accounting firm on June 24, 2026, and the concurrent appointment of BDO Canada LLP as the new auditor. This is a classic auditor change under Item 4.01, with no disagreements, adverse opinions, or reportable events disclosed, indicating a routine transition rather than a crisis-driven change.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-26
Item 1.01
This disclosure describes the entry into and consummation of material definitive agreements involving the sale of a real property facility in Kearny, New Jersey for $38.0 million in cash plus the acquisition of membership interests in Passaic Ventures (which owns a Newark facility). The transaction involves a material disposition and acquisition of assets, fitting the definition of M&A activity under Item 1.01. The $38 million cash consideration and real estate asset exchange would materially affect the registrant's financial position and asset base.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from the Annual Meeting of Shareholders held on June 25, 2026. The filing reports voting outcomes for two matters: (1) election of two board members (Eric Kaye and Victor Woolridge) with detailed vote tallies (For, Against, Abstain, Broker Non-Votes), and (2) ratification of KPMG LLP as independent auditor. Board elections and auditor ratification are material governance matters affecting investor assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from the Company's Annual Meeting of Shareholders held on June 25, 2026. The filing reports voting outcomes on two matters: election of two board members (Eric Kaye and Victor Woolridge) and ratification of KPMG LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) are the hallmark of shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from the Company's Annual Meeting of Shareholders held on June 25, 2026. The filing reports voting outcomes for two matters: (1) election of two board directors (Eric Kaye and Victor Woolridge) and (2) ratification of KPMG LLP as independent auditor. Both proposals passed with substantial majorities. Board elections and auditor ratification are material governance matters affecting investor confidence in corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an Annual Meeting of Shareholders held on June 25, 2026. The filing presents voting results for two matters: (1) election of two board members (Eric Kaye and Victor Woolridge) with detailed vote tallies (For, Against, Abstain, Broker Non-Votes), and (2) ratification of KPMG LLP as independent auditor with similar vote breakdowns. Board elections and auditor ratification are material governance matters affecting investor confidence in corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from the Company's Annual Meeting of Shareholders held on June 25, 2026. The filing reports voting outcomes on two matters: (1) election of two board members (Eric Kaye and Victor Woolridge) and (2) ratification of KPMG LLP as independent auditor. Both proposals passed with substantial majorities, making this a routine but material governance disclosure that affects investor understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-26
Item 5.02
The filing discloses both the departure of CEO Josh Resnik and the appointment of Key Compton as President & Chief Executive Officer effective June 22, 2026. While both events occur, the principal disclosed action centers on the appointment of a new CEO—a material leadership change. The section also mentions Todd Aman's resignation as Chief Legal and Administrative Officer, but the CEO transition is the dominant event. The appointment of Compton, a board member since 2021 with three decades of technology experience, is the forward-looking material event that would affect investor assessment of the company's leadership and direction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a clear disclosure of shareholder vote results from Moelis & Co's 2026 Annual Meeting of Stockholders held on June 25, 2026. The filing reports final vote tabulations for three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of key governance votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This Item 5.07 disclosure reports the results of Blackstone Mortgage Trust's 2026 annual meeting of stockholders held on June 26, 2026, including voting outcomes for three proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies (for, against, withheld, abstained, and broker non-votes) for each matter are the core content of the filing, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →